95 related articles for article (PubMed ID: 12746614)
1. [Metabolic syndrome: to observe or to act?].
Slama G; Picard S
Diabetes Metab; 2003 Apr; 29(2 Pt 3):S5-10. PubMed ID: 12746614
[TBL] [Abstract][Full Text] [Related]
2. Cardiology patient page. The metabolic syndrome.
Lennie TA
Circulation; 2006 Oct; 114(15):e528-9. PubMed ID: 17030691
[No Abstract] [Full Text] [Related]
3. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome: are we at risk?
Paudel B
Nepal Med Coll J; 2007 Sep; 9(3):204-11. PubMed ID: 18092442
[TBL] [Abstract][Full Text] [Related]
5. A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy.
Nobes JP; Langley SE; Klopper T; Russell-Jones D; Laing RW
BJU Int; 2012 May; 109(10):1495-502. PubMed ID: 21933330
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention.
Fu JF; Liang L; Zou CC; Hong F; Wang CL; Wang XM; Zhao ZY
Int J Obes (Lond); 2007 Jan; 31(1):15-22. PubMed ID: 16953257
[TBL] [Abstract][Full Text] [Related]
7. Association of metabolic syndrome components with insulin resistance in normal weight population: the Qazvin Metabolic Diseases study.
Hashemipour S; Esmailzadehha N; Hamid H; Oveisi S; Yakhchaliha P; Ziaee A
J Endocrinol Invest; 2015 Oct; 38(10):1111-5. PubMed ID: 25952300
[TBL] [Abstract][Full Text] [Related]
8. Unmet needs in controlling metabolic disease.
Haffner SM
Rev Cardiovasc Med; 2007; 8 Suppl 4():S17-24. PubMed ID: 17934390
[TBL] [Abstract][Full Text] [Related]
9. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
Chazova I; Almazov VA; Shlyakhto E
Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
[TBL] [Abstract][Full Text] [Related]
10. Endocrine and metabolic characteristics in polycystic ovary syndrome.
Glintborg D
Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034186
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Syndrome: Insulin Resistance and Prediabetes.
Mayans L
FP Essent; 2015 Aug; 435():11-6. PubMed ID: 26280340
[TBL] [Abstract][Full Text] [Related]
12. Treatment of metabolic syndrome.
Wagh A; Stone NJ
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
[TBL] [Abstract][Full Text] [Related]
13. Effect of lifestyle interventions with or without metformin therapy on serum levels of osteoprotegerin and receptor activator of nuclear factor kappa B ligand in patients with prediabetes.
Arslan MS; Tutal E; Sahin M; Karakose M; Ucan B; Ozturk G; Cakal E; Biyikli Gencturk Z; Ozbek M; Delibasi T
Endocrine; 2017 Feb; 55(2):410-415. PubMed ID: 27743302
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
Yamagishi S; Nakamura K; Takeuchi M
Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
[TBL] [Abstract][Full Text] [Related]
15. Hypertension, insulin resistance, and the metabolic syndrome.
Natali A; Ferrannini E
Endocrinol Metab Clin North Am; 2004 Jun; 33(2):417-29. PubMed ID: 15158527
[TBL] [Abstract][Full Text] [Related]
16. [Arterial hypertension and metabolic syndrome].
Christ M; Klima T; Maisch B
Herz; 2003 Dec; 28(8):674-85. PubMed ID: 14689101
[TBL] [Abstract][Full Text] [Related]
17. Metformin improves endothelial function in patients with metabolic syndrome.
Vitale C; Mercuro G; Cornoldi A; Fini M; Volterrani M; Rosano GM
J Intern Med; 2005 Sep; 258(3):250-6. PubMed ID: 16115299
[TBL] [Abstract][Full Text] [Related]
18. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
[TBL] [Abstract][Full Text] [Related]
19. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity.
Cruz ML; Weigensberg MJ; Huang TT; Ball G; Shaibi GQ; Goran MI
J Clin Endocrinol Metab; 2004 Jan; 89(1):108-13. PubMed ID: 14715836
[TBL] [Abstract][Full Text] [Related]
20. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study.
Han TS; Williams K; Sattar N; Hunt KJ; Lean ME; Haffner SM
Obes Res; 2002 Sep; 10(9):923-31. PubMed ID: 12226141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
